Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome

Rainer Ruf(Martin-Luther-Krankenhaus), Friedhelm Hildebrandt(Boston Children's Hospital), Bettina E. Mucha(University of Michigan), Johannes‐Peter Haas(Universitätsmedizin Greifswald), Stephanie M. Karle(Goethe University Frankfurt), Anne Lichtenberger(University of Michigan), Arvind Bagga(All India Institute of Medical Sciences), Anita Imm(University Medical Center Freiburg), Arno Fuchshuber(University Medical Center Freiburg), Isabella Zalewski(University of Michigan), Franzisco E. Anacleto(Philippine General Hospital), Ayşı̇n Bakkaloğlu(Hacettepe University), Eva-Maria Ruf(Boys Town), Thomas J. Neuhaus(University of Zurich), Michael Schultheiß(University of Freiburg)
Journal of the American Society of Nephrology
March 1, 2004
Cited by 415


Related Papers